| Product Code: ETC6752111 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Rare Biomarkers Specimen Collection and Stabilization Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, 2021 & 2031F |
3.3 China Rare Biomarkers Specimen Collection and Stabilization Market - Industry Life Cycle |
3.4 China Rare Biomarkers Specimen Collection and Stabilization Market - Porter's Five Forces |
3.5 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Specimen, 2021 & 2031F |
3.8 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
3.9 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 China Rare Biomarkers Specimen Collection and Stabilization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in China |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in specimen collection and stabilization methods |
4.3 Market Restraints |
4.3.1 Lack of awareness among healthcare professionals about rare biomarkers |
4.3.2 High costs associated with specimen collection and stabilization technologies |
4.3.3 Stringent regulatory requirements for handling rare biomarkers specimens |
5 China Rare Biomarkers Specimen Collection and Stabilization Market Trends |
6 China Rare Biomarkers Specimen Collection and Stabilization Market, By Types |
6.1 China Rare Biomarkers Specimen Collection and Stabilization Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Cell Free DNA (ccfDNA), 2021- 2031F |
6.1.4 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.1.5 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Exosomes/Extracellular Vesicles, 2021- 2031F |
6.2 China Rare Biomarkers Specimen Collection and Stabilization Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Isolation Kits and Reagents, 2021- 2031F |
6.2.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Blood Collection Tubes, 2021- 2031F |
6.2.4 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Systems, 2021- 2031F |
6.3 China Rare Biomarkers Specimen Collection and Stabilization Market, By Specimen |
6.3.1 Overview and Analysis |
6.3.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Serum/Plasma, 2021- 2031F |
6.3.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 China Rare Biomarkers Specimen Collection and Stabilization Market, By Nucleic Acid and other Biomolecules |
6.4.1 Overview and Analysis |
6.4.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By RNA, 2021- 2031F |
6.4.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By DNA, 2021- 2031F |
6.4.4 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Rare Biomarkers Specimen Collection and Stabilization Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By NIPT, 2021- 2031F |
6.5.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.4 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transcriptomics, 2021- 2031F |
6.5.5 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.5.6 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Transplant Rejection, 2021- 2031F |
6.5.7 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Population Screening, 2021- 2031F |
6.5.8 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Rare Biomarkers Specimen Collection and Stabilization Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Perinatal Clinics, 2021- 2031F |
6.6.4 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Public Health Labs, 2021- 2031F |
6.6.5 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Private or Commercial Labs, 2021- 2031F |
6.6.6 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Physician Labs, 2021- 2031F |
6.6.7 China Rare Biomarkers Specimen Collection and Stabilization Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 China Rare Biomarkers Specimen Collection and Stabilization Market Import-Export Trade Statistics |
7.1 China Rare Biomarkers Specimen Collection and Stabilization Market Export to Major Countries |
7.2 China Rare Biomarkers Specimen Collection and Stabilization Market Imports from Major Countries |
8 China Rare Biomarkers Specimen Collection and Stabilization Market Key Performance Indicators |
8.1 Adoption rate of advanced specimen collection and stabilization technologies |
8.2 Number of research collaborations and partnerships in the rare biomarkers sector |
8.3 Rate of new product development and innovation in the specimen collection and stabilization market |
9 China Rare Biomarkers Specimen Collection and Stabilization Market - Opportunity Assessment |
9.1 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Specimen, 2021 & 2031F |
9.4 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Nucleic Acid and other Biomolecules, 2021 & 2031F |
9.5 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 China Rare Biomarkers Specimen Collection and Stabilization Market Opportunity Assessment, By End use, 2021 & 2031F |
10 China Rare Biomarkers Specimen Collection and Stabilization Market - Competitive Landscape |
10.1 China Rare Biomarkers Specimen Collection and Stabilization Market Revenue Share, By Companies, 2024 |
10.2 China Rare Biomarkers Specimen Collection and Stabilization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here